Placemark Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Placemark Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$2.54M	Buy	21,358 +2,123	+11%	+$239K	0.04%	494
2014 Q3	$2.16M	Buy	19,235 +2,610	+16%	+$248K	0.04%	539
2014 Q2	$1.57M	Sell	16,625 -7,367	-31%	-$517K	0.03%	663
2014 Q1	$1.7M	Sell	23,992 -1,530	-6%	-$121K	0.03%	600
2013 Q4	$1.9M	Buy	25,522 +3,873	+18%	+$270K	0.03%	579
2013 Q3	$1.64M	Buy	21,649 +2,363	+12%	+$188K	0.03%	600
2013 Q2	$1.55M	Buy	+19,286	New	+$1.42M	0.03%	586

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Placemark Investments's VRTX Position: Q4 2014 in Review

Placemark Investments increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q4 2014, buying an estimated $239K and bringing the position to 21,358 shares worth $2.54M. The position accounts for 0.04% of the portfolio, ranked #494.

Placemark Investments first reported a position in VRTX in Q2 2013 and has held it in 7 quarters since. 475 funds tracked by Wall St. Rank hold VRTX as of Q4 2014.

Placemark Investments held 21,358 shares of Vertex Pharmaceuticals worth $2.54M as of Q4 2014.
Placemark Investments bought 2,123 Vertex Pharmaceuticals shares in Q4 2014, an estimated $239K.
Vertex Pharmaceuticals made up 0.04% of Placemark Investments's portfolio in Q4 2014, its #494 holding.
Placemark Investments first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
475 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.